Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs PROCTER & GAMBLE HEALTH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PANACEA BIOTECH PROCTER & GAMBLE HEALTH PANACEA BIOTECH/
PROCTER & GAMBLE HEALTH
 
P/E (TTM) x -60.5 34.4 - View Chart
P/BV x 0.9 10.5 8.3% View Chart
Dividend Yield % 0.0 2.0 -  

Financials

 PANACEA BIOTECH   PROCTER & GAMBLE HEALTH
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-23
PROCTER & GAMBLE HEALTH
Jun-23
PANACEA BIOTECH/
PROCTER & GAMBLE HEALTH
5-Yr Chart
Click to enlarge
High Rs1915,366 3.6%   
Low Rs1073,883 2.8%   
Sales per share (Unadj.) Rs75.1740.7 10.1%  
Earnings per share (Unadj.) Rs-5.5138.2 -4.0%  
Cash flow per share (Unadj.) Rs0.9155.2 0.6%  
Dividends per share (Unadj.) Rs095.00 0.0%  
Avg Dividend yield %02.1 0.0%  
Book value per share (Unadj.) Rs137.7447.6 30.8%  
Shares outstanding (eoy) m61.2516.60 369.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.06.2 31.8%   
Avg P/E ratio x-27.133.5 -81.0%  
P/CF ratio (eoy) x170.029.8 570.4%  
Price / Book Value ratio x1.110.3 10.5%  
Dividend payout %068.7 -0.0%   
Avg Mkt Cap Rs m9,14276,761 11.9%   
No. of employees `000NANA-   
Total wages/salary Rs m1,2652,062 61.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m4,59912,296 37.4%  
Other income Rs m517184 280.9%   
Total revenues Rs m5,11612,480 41.0%   
Gross profit Rs m473,247 1.4%  
Depreciation Rs m391281 139.2%   
Interest Rs m448 576.2%   
Profit before tax Rs m1283,142 4.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m466847 54.9%   
Profit after tax Rs m-3372,295 -14.7%  
Gross profit margin %1.026.4 3.9%  
Effective tax rate %363.527.0 1,348.1%   
Net profit margin %-7.318.7 -39.3%  
BALANCE SHEET DATA
Current assets Rs m5,62311,713 48.0%   
Current liabilities Rs m3,2976,791 48.6%   
Net working cap to sales %50.640.0 126.3%  
Current ratio x1.71.7 98.9%  
Inventory Days Days59263 22.3%  
Debtors Days Days48343 13.9%  
Net fixed assets Rs m7,02810,617 66.2%   
Share capital Rs m61166 36.9%   
"Free" reserves Rs m8,3757,265 115.3%   
Net worth Rs m8,4367,431 113.5%   
Long term debt Rs m2020-   
Total assets Rs m12,71222,330 56.9%  
Interest coverage x3.9409.1 0.9%   
Debt to equity ratio x00-  
Sales to assets ratio x0.40.6 65.7%   
Return on assets %-2.310.3 -22.4%  
Return on equity %-4.030.9 -13.0%  
Return on capital %2.042.4 4.7%  
Exports to sales %43.30-   
Imports to sales %24.413.1 187.1%   
Exports (fob) Rs m1,992NA-   
Imports (cif) Rs m1,1241,605 70.0%   
Fx inflow Rs m1,9921,465 136.0%   
Fx outflow Rs m1,1911,605 74.2%   
Net fx Rs m801-140 -571.6%   
CASH FLOW
From Operations Rs m-4,2252,360 -179.0%  
From Investments Rs m4,303-215 -2,001.5%  
From Financial Activity Rs m-184-985 18.7%  
Net Cashflow Rs m-1051,160 -9.0%  

Share Holding

Indian Promoters % 73.6 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 1.0 20.3 4.7%  
FIIs % 0.3 7.6 3.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.4 48.2 54.8%  
Shareholders   47,091 56,730 83.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PANACEA BIOTECH With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Panacea Biotech vs Procter & Gamble Health

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Panacea Biotech vs Procter & Gamble Health Share Price Performance

Period Panacea Biotech Procter & Gamble Health S&P BSE HEALTHCARE
1-Day -2.47% -0.69% 1.18%
1-Month -20.61% -7.59% -0.75%
1-Year 10.92% -3.15% 61.82%
3-Year CAGR -12.48% -9.16% 18.16%
5-Year CAGR -10.11% 5.72% 19.79%

* Compound Annual Growth Rate

Here are more details on the Panacea Biotech share price and the Procter & Gamble Health share price.

Moving on to shareholding structures...

The promoters of Panacea Biotech hold a 73.6% stake in the company. In case of Procter & Gamble Health the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Panacea Biotech and the shareholding pattern of Procter & Gamble Health.

Finally, a word on dividends...

In the most recent financial year, Panacea Biotech paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

Procter & Gamble Health paid Rs 95.0, and its dividend payout ratio stood at 68.7%.

You may visit here to review the dividend history of Panacea Biotech, and the dividend history of Procter & Gamble Health.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.